S20-084 CDK19- Selective Inhibitors, and Methods of Use thereof Researchers at Stanford University have identified new CDK19-selective inhibitors for the treatment of triple negative breast cancer. Robert Hsieh Mark Smith Michael Clarke Vinnie Alford Andre St. Amant
S17-013 METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed a method for treating and predicting treatment efficacy of triple negative breast cancer (TNBC). Michael Clarke Robert Hsieh